See more : 111, Inc. (YI) Income Statement Analysis – Financial Results
Complete financial analysis of SeaStar Medical Holding Corporation (ICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SeaStar Medical Holding Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- SmartMetric, Inc. (SMME) Income Statement Analysis – Financial Results
- Aichi Corporation (6345.T) Income Statement Analysis – Financial Results
- JinFu Technology Co., Ltd. (003018.SZ) Income Statement Analysis – Financial Results
- Uniplus Electronics Co., Ltd. (5381.TWO) Income Statement Analysis – Financial Results
- Portex Minerals Inc. (STACF) Income Statement Analysis – Financial Results
SeaStar Medical Holding Corporation (ICU)
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.97M | 2.82M | 2.77M | 4.03M |
| General & Administrative | 8.01M | 6.60M | 1.68M | 2.43M |
| Selling & Marketing | 32.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.04M | 6.60M | 1.68M | 2.43M |
| Other Expenses | 200.00K | 0.00 | 91.00K | 84.00K |
| Operating Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Cost & Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Interest Income | 0.00 | 630.00 | 212.00 | 3.31K |
| Interest Expense | 1.08M | 630.00K | 212.00K | 3.31M |
| Depreciation & Amortization | 14.01M | 11.61M | 4.45M | 6.45M |
| EBITDA | -11.14M | -11.61M | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.21M | -11.61M | -4.45M | -6.45M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -12.02M | -11.40M | -148.00K | 3.19M |
| Income Before Tax | -26.23M | -23.01M | -4.60M | -3.27M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.00K | -1.00K | 9.00K |
| Net Income | -26.23M | -23.01M | -4.60M | -3.28M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -30.29 | -70.16 | -15.90 | -27.15 |
| EPS Diluted | -30.26 | -70.07 | -15.87 | -27.15 |
| Weighted Avg Shares Out | 866.00K | 328.00K | 289.00K | 120.67K |
| Weighted Avg Shares Out (Dil) | 866.81K | 328.45K | 289.55K | 120.67K |
Contact Levi & Korsinsky by September 6, 2024 Deadline to Join Class Action Against SeaStar Medical Holding Corporation(ICU)
NEW YORK, NY / ACCESSWIRE / September 1, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ICU
NEW YORK, NY / ACCESSWIRE / September 1, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines – ICU
NEW YORK, NY / ACCESSWIRE / September 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ:ICU) and certain officers. The class action, filed in the...
September 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ICU
NEW YORK, NY / ACCESSWIRE / September 1, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation Is Being Sued For Potential Securities Fraud And Affected Investors Should Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of...
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK CITY, NY / ACCESSWIRE / September 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company")...
Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / September 1, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Levi & Korsinsky Notifies Shareholders of SeaStar Medical Holding Corporation(ICU) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / August 31, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In SeaStar To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in SeaStar stock or options between...
The Schall Law Firm Seeks Individuals With Losses In SeaStar Medical Holding Corporation To Assist With A Lawsuit For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of...
Source: https://incomestatements.info
Category: Stock Reports